Drugs / PIpepTolDC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04590872 | Jun 2022 → Jun 2024 overdue | type 1 diabetes mellitus | City of Hope Medical Center | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PIpepTolDC | “Autologous Tolerogenic Dendritic Cell with Proinsulin Peptide (PIpepTolDC)” NCT04590872 ↗ |
| Modality | Vaccine | “PIpepTolDC vaccine” NCT04590872 ↗ |